Omega-3 and heart disease
This article was originally published in The Tan Sheet
Executive Summary
Fatty fish oils "can help lower high blood pressure slightly [and] may reduce risk of coronary artery re-blockage after angioplasty," the Agency for Healthcare Research & Quality states April 22. AHRQ completed five systematic literature reviews at the request of the NIH Office of Dietary Supplements evaluating omega-3's relationship to cardiovascular disease, cardiovascular risk factors, asthma and type II diabetes, among other conditions. Results revealed fatty acids' link to asthma requires more research, but that omega-3s "do not affect fasting blood sugar...in people with type II diabetes." Studies were carried out at AHRQ's Evidence Based Research Centers in the U.S. and Canada...
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.